信立泰(002294)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002294 信立泰

交易中 05-28 14:05:18

{"stockData":{"symbol":"002294","market":"SZ","secType":"STK","nameCN":"信立泰","latestPrice":26.94,"timestamp":1716876318000,"preClose":27.37,"halted":0,"volume":2847659,"delay":0,"floatShares":1115000000,"shares":1115000000,"eps":0.5108,"marketStatus":"交易中","marketStatusCode":2,"change":-0.43,"latestTime":"05-28 14:05:18","open":27.28,"high":27.38,"low":26.94,"amount":77188900,"amplitude":0.0161,"askPrice":26.94,"askSize":43,"bidPrice":26.93,"bidSize":39,"shortable":0,"etf":0,"ttmEps":0.5108,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1716879600000},"adr":0,"adjPreClose":27.37,"symbolType":"stock","openAndCloseTimeList":[[1716859800000,1716867000000],[1716872400000,1716879600000]],"highLimit":30.11,"lowLimit":24.63,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1114816535,"pbRate":3.71,"roa":"--","roe":"2.47%","epsLYR":0.52,"committee":0.64751,"marketValue":30033000000,"floatMarketCap":30026000000,"peRate":52.740798,"changeRate":-0.0157,"turnoverRate":0.0026,"status":1},"requestUrl":"/m/hq/s/002294","defaultTab":"news","newsList":[{"id":"2437924954","title":"信立泰(002294.SZ)：阿利沙坦酯氨氯地平片(复立坦®)获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2437924954","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2437924954?lang=zh_cn&edition=full","pubTime":"2024-05-21 18:03","pubTimestamp":1716285805,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信立泰 发布公告，近日，公司收到国家药品监督管理局核准签发的阿利沙坦酯氨氯地平片(复立坦)药品注册证书。据悉，阿利沙坦酯氨氯地平片(复立坦)用于治疗原发性高血压，适用于单用阿利沙坦酯或单用氨氯地平治疗血压控制效果不佳的成人患者，为国产原研ARB/CCB类复方制剂。其组分经典，可靠性高，降压疗效得到充分验证。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1123945.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2436913093","title":"信立泰：截至2月8日，公司股东人数27,215","url":"https://stock-news.laohu8.com/highlight/detail?id=2436913093","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2436913093?lang=zh_cn&edition=full","pubTime":"2024-05-17 20:04","pubTimestamp":1715947485,"startTime":"0","endTime":"0","summary":"投资者：请问截止2月8日收盘公司股东人数是多少？截至3月8日，公司股东人数29,469。公司大股东未减持股份，其持有公司63527.938万股，占公司总股本约56.99%。经问询股东，近期中信里昂资产管理有限公司－客户资金发生大宗交易合计股数1922.55万股，目前持有股份数占公司总股本约2.97%。恩那罗23年6月获批上市，23年12月通过谈判首次纳入医保目录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051700043030.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2436375789","title":"信立泰（002294）5月16日主力资金净卖出172.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2436375789","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2436375789?lang=zh_cn&edition=full","pubTime":"2024-05-17 09:22","pubTimestamp":1715908949,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月16日收盘，信立泰报收于29.56元，下跌1.6%，换手率0.28%，成交量3.1万手，成交额9239.97万元。近5日资金流向一览见下表：信立泰融资融券信息显示，融资方面，当日融资买入1009.35万元，融资偿还783.25万元，融资净买入226.1万元。信立泰主营业务：药品、医疗器械产品的研发、生产、销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051700015548.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435341613","title":"信立泰(002294.SZ)股东润复拟向基金会无偿捐赠200万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435341613","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435341613?lang=zh_cn&edition=full","pubTime":"2024-05-13 16:58","pubTimestamp":1715590732,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信立泰(002294.SZ)公告，公司近日收到股东深圳市润复投资发展有限公司(下称“润复”)《关于无偿捐赠部分股份的告知函》，其计划将所持有的无限售条件流通股200万股(占公司总股本比例0.18%)无偿捐赠给深圳市叶澄海慈善基金会(下称“基金会”)。基金会出售股份所得款项，将全部用于捐资助学等公益事业。其中，将定向捐赠不少于5000万元人民币给深圳大学，剩余款项将用于基金会开展慈善公益活动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1120493.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435499543","title":"5月13日信立泰现4.96亿元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2435499543","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435499543?lang=zh_cn&edition=full","pubTime":"2024-05-13 16:40","pubTimestamp":1715589649,"startTime":"0","endTime":"0","summary":"证券之星消息，5月13日信立泰发生大宗交易，交易数据如下：大宗交易成交价格30.72元，成交1613.33万股，成交金额49561.5万元，买方营业部为机构专用，卖方营业部为机构专用。近三个月该股共发生2笔大宗交易，合计成交35.36万手，折价成交1笔。截至2024年5月13日收盘，信立泰报收于30.72元，下跌1.57%，换手率0.31%，成交量3.42万手，成交额1.05亿元。该股最近90天内共有10家机构给出评级，买入评级8家，增持评级2家；过去90天内机构目标均价为38.57。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300015974.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433296337","title":"天风证券：给予信立泰买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2433296337","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433296337?lang=zh_cn&edition=full","pubTime":"2024-05-07 10:56","pubTimestamp":1715050595,"startTime":"0","endTime":"0","summary":"天风证券股份有限公司杨松,曹文清近期对信立泰进行研究并发布了研究报告《2023年业绩基本稳定，2024年Q1收入增长回正》，本报告对信立泰给出买入评级，当前股价为31.42元。该团队在推广信立坦产品方面已展现出明显成效，预计未来将继续利用其优势，推动公司业务的进一步增长。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有9家机构给出评级，买入评级7家，增持评级2家；过去90天内机构目标均价为38.57。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050700017456.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433445367","title":"信立泰（002294）股东信立泰药业有限公司质押1600万股，占总股本1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433445367","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433445367?lang=zh_cn&edition=full","pubTime":"2024-05-06 03:30","pubTimestamp":1714937442,"startTime":"0","endTime":"0","summary":"证券之星消息，信立泰5月6日公开信息显示，股东信立泰药业有限公司向澳门国际银行股份有限公司合计质押1600.0万股，占总股本1.44%。质押详情见下表：截止本公告日，股东信立泰药业有限公司已累计质押股份2.0亿股，占其持股总数的31.53%。信立泰主营业务：药品、医疗器械产品的研发、生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050600000074.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429125657","title":"信立泰（002294）2024年一季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2429125657","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429125657?lang=zh_cn&edition=full","pubTime":"2024-04-24 06:15","pubTimestamp":1713910533,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期信立泰发布2024年一季报。根据财报显示，本报告期中信立泰增收不增利。截至本报告期末，公司营业总收入10.91亿元，同比上升22.92%，归母净利润2.0亿元，同比下降5.06%。重仓信立泰的前十大基金见下表：持有信立泰最多的基金为广发医疗保健股票A，目前规模为58.21亿元，最新净值1.6097，较上一交易日上涨1.85%，近一年下跌24.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400012002.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429660165","title":"信立泰(002294)3月31日股东户数2.83万户，较上期减少3.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429660165","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429660165?lang=zh_cn&edition=full","pubTime":"2024-04-23 17:07","pubTimestamp":1713863234,"startTime":"0","endTime":"0","summary":"证券之星消息，近日信立泰披露，截至2024年3月31日公司股东户数为2.83万户，较2月29日减少1009.0户，减幅为3.44%。在化学制药行业个股中，信立泰股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.34万户。从股价来看，2024年2月29日至2024年3月31日，信立泰区间跌幅为0.31%，在此期间股东户数减少1009.0户，减幅为3.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300032951.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429216892","title":"4月23日信立泰涨6.08%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429216892","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429216892?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:30","pubTimestamp":1713861049,"startTime":"0","endTime":"0","summary":"证券之星消息，4月23日信立泰涨6.08%，收盘报30.55元，换手率0.79%，成交量8.76万手，成交额2.62亿元。重仓信立泰的前十大公募基金请见下表：该股最近90天内共有9家机构给出评级，买入评级7家，增持评级2家；过去90天内机构目标均价为38.57。根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共22家，其中持有数量最多的公募基金为广发医疗保健股票A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300029888.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429168998","title":"信立泰涨6.08%，华安证券三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429168998","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429168998?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:30","pubTimestamp":1713861043,"startTime":"0","endTime":"0","summary":"今日信立泰涨6.08%，收盘报30.55元。2024年4月2日，华安证券研究员谭国超发布了对信立泰的研报《23FY符合预期Q4恢复明显，创新转型出海进程兑现》，该研报对信立泰给出“买入”评级。我们看好公司创新转型带来的收入结构重塑，在心血管领域的多年耕耘，老产品医保及集采降价即将触底，维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为67.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300029885.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429972660","title":"图解信立泰一季报：第一季度单季净利润同比减5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429972660","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429972660?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:48","pubTimestamp":1713808091,"startTime":"0","endTime":"0","summary":"证券之星消息，信立泰2024年一季报显示，公司主营收入10.91亿元，同比上升22.92%；归母净利润2.0亿元，同比下降5.06%；扣非净利润2.01亿元，同比上升4.5%；负债率14.02%，投资收益123.16万元，财务费用-1136.85万元，毛利率71.45%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300002234.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429492130","title":"信立泰最新公告：一季度净利润2亿元 同比下降5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429492130","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429492130?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:30","pubTimestamp":1713792651,"startTime":"0","endTime":"0","summary":"信立泰公告，公司2024年第一季度实现营业收入10.91亿元，同比增长22.92%（调整后）；净利润2亿元，同比下降5.06%（调整后）。同日公告，拟以自筹资金3500万美元（或等值其他币种，约合人民币2.56亿元）向控股子公司Salubris Bio增资。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200029373.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429295979","title":"信立泰(002294.SZ)发一季度业绩，净利润2亿元，同比减少5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429295979","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429295979?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:27","pubTimestamp":1713792432,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信立泰(002294.SZ)发布2024年一季度报告，营业收入10.91亿元，同比增长22.92%。归属于上市公司股东的净利润2亿元，同比减少5.06%。归属于上市公司股东的扣除非经常性损益的净利润2.01亿元，同比增长4.50%。基本每股收益0.180元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107046.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429295139","title":"信立泰(002294.SZ)拟以自筹资金3500万美元向Salubris Bio增资","url":"https://stock-news.laohu8.com/highlight/detail?id=2429295139","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429295139?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:24","pubTimestamp":1713792270,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信立泰 发布公告，Salubris Biotherapeutics, Inc.为公司位于美国的创新生物制药研发中心，由公司通过全资子公司诺泰国际有限公司等公司实现逐级控股。为进一步支持创新生物制药发展，加快生物药海外研发进程，公司拟以自筹资金3500万美元向Salubris Bio 增资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107039.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422164843","title":"华金证券：给予信立泰买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2422164843","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2422164843?lang=zh_cn&edition=full","pubTime":"2024-03-28 19:11","pubTimestamp":1711624260,"startTime":"0","endTime":"0","summary":"华金证券股份有限公司赵宁达近期对信立泰进行研究并发布了研究报告《创新营收贡献增强，降压管线进入密集收获期》，本报告对信立泰给出买入评级，当前股价为28.87元。公司全年业绩略有下滑，主要受泰嘉续标降价及天津、福建等地丢标影响。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家；过去90天内机构目标均价为36.74。以上内容由证券之星根据公开信息整理，由算法生成，与本站立场无关。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-03-28/doc-inapwqvs2231175.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-03-28/doc-inapwqvs2231175.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422515556","title":"信立泰：2023年净利同比降8.95% 拟10派5元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422515556","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2422515556?lang=zh_cn&edition=full","pubTime":"2024-03-25 19:51","pubTimestamp":1711367460,"startTime":"0","endTime":"0","summary":"格隆汇3月25日｜信立泰公告，2023年实现营业收入33.65亿元，同比下降3.35%；净利润5.8亿元，同比下降8.95%；基本每股收益0.52元。公司拟每10股派发现金红利5元(含税)。               \n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-03-25/doc-inappxsk1409717.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-03-25/doc-inappxsk1409717.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2391648532","title":"医保谈判，这次是真爱","url":"https://stock-news.laohu8.com/highlight/detail?id=2391648532","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2391648532?lang=zh_cn&edition=full","pubTime":"2023-12-13 15:50","pubTimestamp":1702453833,"startTime":"0","endTime":"0","summary":"利好长周期大品种","market":"hk","thumbnail":"https://img3.gelonghui.com/dbdf8-b5852b41-4067-401b-aecf-07e8acd90fde.jpg","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/dbdf8-b5852b41-4067-401b-aecf-07e8acd90fde.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/673298","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2009-09-10","address":"广东省深圳市福田区福保街道福保社区红柳道2号289数字半岛4层A区","stockEarnings":[{"period":"1week","weight":-0.0697},{"period":"1month","weight":-0.1244},{"period":"3month","weight":-0.0539},{"period":"6month","weight":-0.1859},{"period":"1year","weight":-0.2418},{"period":"ytd","weight":-0.162}],"companyName":"深圳信立泰药业股份有限公司","boardCode":"AI0027","perCapita":"41336股","boardName":"医药制造业","registeredCapital":"111481万元","compareEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":0.0115},{"period":"3month","weight":0.036},{"period":"6month","weight":0.0339},{"period":"1year","weight":-0.0275},{"period":"ytd","weight":0.0501}],"survey":"　　深圳信立泰药业股份有限公司主营业务是药品、医疗器械产品的研发、生产、销售。主要产品心血管类药物及医疗器械、头孢类抗生素及原料、骨科药物等。","serverTime":1716876318735,"listedPrice":41.98,"stockholders":"26963人(较上一季度减少2.58%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"信立泰(002294)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供信立泰(002294)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"信立泰,002294,信立泰股票,信立泰股票老虎,信立泰股票老虎国际,信立泰行情,信立泰股票行情,信立泰股价,信立泰股市,信立泰股票价格,信立泰股票交易,信立泰股票购买,信立泰股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"信立泰(002294)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供信立泰(002294)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}